West Virginia Code of State Rules › Agency 69 - Health And Human Resources › Title 69 - LEGISLATIVE RULE DEPARTMENT OF HEALTH AND HUMAN RESOURCES › Series 69-11 - Medication-Assisted Treatment - Opioid Treatment Programs › Section 69-11-21 - Pre-Admission Assessment; Admission Criteria and Admission Process

Current through Register Vol. XLI, No. 28, July 12, 2024
21.1. Each MAT
				program shall develop, implement and maintain policies and procedures designed
				to ensure that patients are admitted to maintenance treatment only after
				assessment by qualified personnel who have determined that the person meets the
				qualifications for admission.
21.2.
				Any individual seeking admittance to the MAT program shall undergo a
				pre-admission initial assessment in order to determine whether the person meets
				the criteria for admission to a MAT program. The initial assessment, consisting
				of a physical assessment and an intake screening, shall be conducted by the
				medical director, an approved program physician or a supervised physician
				extender. The initial assessment shall focus on the individual's eligibility
				and need for treatment and shall provide indicators for initial dosage level,
				if required and if admission is determined appropriate. The determination of
				admission eligibility shall be made using accepted medical criteria such as
				those listed in the latest approved version of the Diagnostic and Statistical
				Manual for Mental Disorders.
21.3.
				The initial physical assessment shall include documentation of:
21.3.a. A brief physical
				examination;
21.3.b. The patient's
				immediately relevant history, including, but not limited to, determination of
				chronic or acute medical conditions such as diabetes, renal disease, hepatitis,
				sickle cell anemia, tuberculosis, human immunodeficiency virus (HIV) exposure,
				sexually transmitted disease, chronic cardiopulmonary disease and
				pregnancy;
21.3.c. A determination
				of currently prescribed medication or utilized over-the-counter
				substances;
21.3.d. An evaluation
				of the patient's use of other substances of abuse and alcohol;
21.3.e. Determination of current substance
				use disorder;
21.3.f. Determination
				of length of substance use disorder;
21.3.g. An initial drug test and full drug
				screen to identify whether the patient is using other drugs, including opiates,
				methadone, buprenorphine, amphetamines, cocaine, barbiturates, benzodiazepines,
				marijuana or other drugs or substances as determined by community standards,
				regional variation or clinical indication, such as carisoprodol; to determine
				whether the individual has a substance use disorder from another MAT
				program;
21.3.h. An inquiry to and
				report from the Controlled Substances Monitoring Program database;
21.3.i. An inquiry whether the patient is
				enrolled in any other MAT program;
21.3.j. Identify comorbid medical and
				psychiatric conditions or disorders and to determine how, when and where they
				will be addressed;
21.3.k. Screen
				for communicable diseases and address them as needed and evaluate patient's
				level of physical, psychological and social functioning or
				impairment;
21.3.l. Assess the
				individual's access to social supports, family, friends, employment, housing,
				finances and whether any legal problems exist; and
21.3.m. Determine the patient's readiness to
				participate in treatment.